SCHEMBL7784694

SCHEMBL7784694

Cc1cc(NCC(=O)O)c([N+](=O)[O-])cc1Cl.[NaH]

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
MAPT P10636 5/20 0.46
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
HCAR3 P49019 2/20 0.41
LMNA P02545 2/20 0.41
BCL6 P41182 1/20 0.40
BCOR Q6W2J9 1/20 0.40
RECQL P46063 1/20 0.40
HTT P42858 1/20 0.39
KDM4E B2RXH2 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
HPGD P15428 1/20 0.39
MAPK1 P28482 1/20 0.39
CYP2C19 P33261 1/20 0.39
PTGDR Q13258 1/20 0.39
PPIA P62937 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7786651 0.97 ALDH1A1 (0.47) ALDH1A1MAPTNPC1RAB9AMEN1
SCHEMBL7786655 0.94 ALDH1A1 (0.47) ALDH1A1MAPTNPC1RAB9AMEN1
SCHEMBL7779743 0.93 ALDH1A1 (0.48) ALDH1A1MAPTNPC1RAB9AMEN1
Potassium Ion SCHEMBL7786648 0.86 MEN1 (0.42) ALDH1A1MAPTNPC1RAB9AMEN1
SCHEMBL7784692 0.86 MEN1 (0.42) ALDH1A1MAPTNPC1RAB9AMEN1
SCHEMBL7784833 0.85 ALDH1A1 (0.46) ALDH1A1MAPTKMT2AHCAR3LMNA
SCHEMBL7786791 0.83 ALDH1A1 (0.50) ALDH1A1MAPTMEN1KMT2AHCAR3
SCHEMBL7786592 0.83 ALDH1A1 (0.50) ALDH1A1MAPTNPC1RAB9AMEN1
SCHEMBL7786717 0.83 ALDH1A1 (0.47) ALDH1A1MAPTNPC1RAB9AMEN1
SCHEMBL7784744 0.83 ALDH1A1 (0.47) ALDH1A1MAPTMEN1KMT2AHCAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6251903-B1 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonist COCENSYS, INC. 2001-06-26 US disclosed
US-6147075-A ANALGESICS; PSYCHOLOGICAL DISORDERS COCENSYS, INC. (US) 2000-11-14 US disclosed
EP-0732942-A4 ALKYL, AZIDO, ALKOXY, AND FLUORO-SUBSTITUTED AND FUSED QUINOXALINEDIONES AND THE USE THEREOF AS GLYCINE RECEPTOR ANTAGONISTS COCENSYS INC (US) 2000-03-22 EP disclosed
US-5977107-A Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists COCENSYS, INC. (US) 1999-11-02 US disclosed
US-5631373-A NERVOUS SYSTEM DISORDERS STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE OREGON (US) 1997-05-20 US disclosed
EP-0732942-A1 ALKYL, AZIDO, ALKOXY, AND FLUORO-SUBSTITUTED AND FUSED QUINOXALINEDIONES AND THE USE THEREOF AS GLYCINE RECEPTOR ANTAGONISTS ACEA PHARMACEUTICALS, INC. (US) 1996-09-25 EP disclosed
WO-1995012417-A1 ALKYL, AZIDO, ALKOXY, AND FLUORO-SUBSTITUTED AND FUSED QUINOXALINEDIONES AND THE USE THEREOF AS GLYCINE RECEPTOR ANTAGONISTS ACEA PHARMACEUTICALS, INC. (US) 1995-05-11 WO disclosed